74 related articles for article (PubMed ID: 19543207)
21. Role of endothelin ET(A) and ET(B) receptor subtypes in the regulation of intrarenal blood flow and oxygen tension in rats.
Nitescu N; Grimberg E; Herlitz H; Guron G
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1227-32. PubMed ID: 18518881
[TBL] [Abstract][Full Text] [Related]
22. Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure.
Hand MF; Haynes WG; Webb DJ
Kidney Int; 1999 Feb; 55(2):613-20. PubMed ID: 9987085
[TBL] [Abstract][Full Text] [Related]
23. Endothelin does not contribute to the attenuation in myocardial function and blood flow after repetitive ischemia in the rat heart.
Tiefenbacher CP; Tweddell A; Batkai S; Zimmermann R; Tillmanns H; Kübler W
J Vasc Res; 1997; 34(6):447-54. PubMed ID: 9425997
[TBL] [Abstract][Full Text] [Related]
24. Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation.
Quercioli A; Pataky Z; Montecucco F; Carballo S; Thomas A; Staub C; Di Marzo V; Vincenti G; Ambrosio G; Ratib O; Golay A; Mach F; Harsch E; Schindler TH
JACC Cardiovasc Imaging; 2012 Aug; 5(8):805-15. PubMed ID: 22897994
[TBL] [Abstract][Full Text] [Related]
25. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1.
Takagi C; Bursell SE; Lin YW; Takagi H; Duh E; Jiang Z; Clermont AC; King GL
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2504-18. PubMed ID: 8933767
[TBL] [Abstract][Full Text] [Related]
26. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
Halcox JP; Nour KR; Zalos G; Quyyumi AA
Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
[TBL] [Abstract][Full Text] [Related]
27. Endothelin A receptor blockade improves endothelium-dependent relaxation in obese woman.
Gradin K; Persson B
Physiol Res; 2018 Jun; 67(Suppl 1):S167-S174. PubMed ID: 29947537
[TBL] [Abstract][Full Text] [Related]
28. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
[TBL] [Abstract][Full Text] [Related]
29. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men.
Böhm F; Pernow J; Lindström J; Ahlborg G
Clin Sci (Lond); 2003 Feb; 104(2):143-51. PubMed ID: 12546636
[TBL] [Abstract][Full Text] [Related]
30. Endothelin-1 and vascular tone in subjects with atherogenic risk factors.
Nohria A; Garrett L; Johnson W; Kinlay S; Ganz P; Creager MA
Hypertension; 2003 Jul; 42(1):43-8. PubMed ID: 12756218
[TBL] [Abstract][Full Text] [Related]
31. High serum leptin is associated with attenuated coronary vasoreactivity.
Sundell J; Huupponen R; Raitakari OT; Nuutila P; Knuuti J
Obes Res; 2003 Jun; 11(6):776-82. PubMed ID: 12805399
[TBL] [Abstract][Full Text] [Related]
32. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.
Homma N; Nagaoka T; Morio Y; Ota H; Gebb SA; Karoor V; McMurtry IF; Oka M
J Cardiovasc Pharmacol; 2007 Dec; 50(6):697-702. PubMed ID: 18091588
[TBL] [Abstract][Full Text] [Related]
33. Physiology of endothelin in producing myocardial perfusion heterogeneity: a mechanistic study using darusentan and positron emission tomography.
Johnson NP; Gould KL
J Nucl Cardiol; 2013 Oct; 20(5):835-44. PubMed ID: 23842710
[TBL] [Abstract][Full Text] [Related]
34. Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients.
Passauer J; Lässig G; Büssemaker E; Pistrosch F; Gross P
Kidney Int; 2004 May; 65(5):1782-9. PubMed ID: 15086917
[TBL] [Abstract][Full Text] [Related]
35. Endothelin B receptors preserve renal blood flow in a normotensive model of endotoxin-induced acute kidney dysfunction.
Nitescu N; Grimberg E; Ricksten SE; Herlitz H; Guron G
Shock; 2008 Mar; 29(3):402-9. PubMed ID: 17693943
[TBL] [Abstract][Full Text] [Related]
36. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.
Böhm F; Ahlborg G; Pernow J
Clin Sci (Lond); 2002 Mar; 102(3):321-7. PubMed ID: 11869173
[TBL] [Abstract][Full Text] [Related]
37. Endothelin 1 versus endothelin 3 in the development of the slow force response to myocardial stretch.
Ros MN; Dulce RA; Pérez NG; Camilión de Hurtado MC; Cingolani HE
Can J Cardiol; 2005 Apr; 21(5):435-8. PubMed ID: 15861262
[TBL] [Abstract][Full Text] [Related]
38. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
39. Endothelin-A receptors mediate renal hemodynamic effects of exogenous Angiotensin II in humans.
Montanari A; Biggi A; Carra N; Ziliotti M; Fasoli E; Musiari L; Perinotto P; Novarini A
Hypertension; 2003 Oct; 42(4):825-30. PubMed ID: 12925560
[TBL] [Abstract][Full Text] [Related]
40. Effects of thrombolytic drugs and a selective endothelin-1 receptor antagonist on acute pulmonary thromboembolism in dogs.
Han L; Li QY; Zhou L; Wang X; Bao ZY; Li M; Wan HY; Shi GC
Chin Med J (Engl); 2010 Feb; 123(4):395-400. PubMed ID: 20193475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
